NGL Fine Chem September-quarter profit rises 69% to Rs 16.25 crore
Key highlights
- NGL Fine Chem’s September-quarter consolidated profit rose 69% year on year to Rs 16.25 crore.
- NGL Fine Chem’s September-quarter revenue from operations increased 32% to Rs 158.71 crore.
- NGL Fine Chem’s half-year consolidated profit after tax rose 84% to Rs 34.64 crore.
- NGL Fine Chem spent Rs 44.25 crore on capital expenditure in the half year ended September 2026.
powered by IRIS

NGL Fine Chem Limited reported consolidated profit after tax of Rs 16.25 crore for the quarter ended September 30, 2026, up 69% from Rs 9.63 crore a year earlier, as revenue from operations increased 32% to Rs 158.71 crore. The Board approved the unaudited results on November 6, 2026.
Know NGL Fine Chem inside out
Results, valuation, peers and who's buying, in one view.
What were NGL Fine Chem’s September-quarter earnings?
NGL Fine Chem’s consolidated profit after tax was Rs 16.25 crore in the quarter ended September 30, 2026, compared with Rs 9.63 crore in the quarter ended September 30, 2025 and Rs 18.40 crore in the quarter ended June 30, 2026. The year-on-year increase followed higher revenue, while profit after tax was 12% below the preceding quarter.
Consolidated profit before tax was Rs 21.60 crore, compared with Rs 12.96 crore a year earlier and Rs 24.48 crore in the June 2026 quarter. The difference between September-quarter profit before tax and profit after tax was Rs 5.35 crore, versus Rs 3.34 crore in the corresponding quarter of 2025.
Other comprehensive income, net of tax, was Rs 16.58 lakh in the September 2026 quarter, taking total comprehensive income to Rs 16.41 crore. Total comprehensive income was Rs 9.76 crore in the September 2025 quarter and Rs 18.04 crore in the June 2026 quarter.
How did NGL Fine Chem’s revenue and expenses change?
NGL Fine Chem’s revenue from operations rose to Rs 158.71 crore from Rs 120.26 crore a year earlier and Rs 139.16 crore in the preceding quarter. Other income fell to Rs 1.20 crore from Rs 2.05 crore in the September 2025 quarter, but total revenue still increased to Rs 159.91 crore from Rs 122.31 crore.
Material consumption increased to Rs 86.77 crore from Rs 61.89 crore, employee-benefit expense rose to Rs 21.19 crore from Rs 15.70 crore, and other expenses increased to Rs 40.04 crore from Rs 30.14 crore. Depreciation and amortisation expense was Rs 6.55 crore, compared with Rs 5.09 crore a year earlier.
The company recorded a Rs 17.36 crore reduction in stock-in-trade and work in progress as an expense offset, compared with a Rs 4.62 crore reduction in the September 2025 quarter. Total expenses rose to Rs 138.31 crore from Rs 109.35 crore, an increase of 26%, compared with a 31% rise in total revenue.
Finance costs were Rs 1.12 crore in the September 2026 quarter, compared with Rs 1.16 crore a year earlier and Rs 98.51 lakh in the June 2026 quarter. The results statement shows no exceptional items in the three quarterly consolidated columns, so profit before tax had no exceptional-item adjustment.
Got a follow-up? Ask IRIS
What do NGL Fine Chem’s half-year results show?
NGL Fine Chem reported consolidated profit after tax of Rs 34.64 crore for the half year ended September 30, 2026, up 84% from Rs 18.87 crore in the corresponding period of 2025. Revenue from operations increased 33% to Rs 297.87 crore from Rs 224.44 crore, while total revenue increased to Rs 306.50 crore from Rs 232.85 crore.
Profit before tax for the six-month period was Rs 46.07 crore, compared with Rs 24.80 crore a year earlier. Total expenses were Rs 260.43 crore, versus Rs 208.05 crore, including Rs 167.25 crore of material consumption, Rs 40.11 crore of employee-benefit expense and Rs 75.58 crore of other expenses.
Basic and diluted earnings per share for the half year were Rs 56.08, compared with Rs 30.54 in the corresponding 2025 period. The filing states that quarterly earnings per share are not annualised, and it reports a face value of Rs 5 per equity share.
NGL Fine Chem identifies pharmaceuticals as its single business segment under Indian Accounting Standard 108, or Ind AS 108. The consolidated figures include Macrotech Polychem Private Limited, its wholly owned subsidiary, rather than solely the parent company’s standalone results.
What changed in NGL Fine Chem’s cash flow and balance sheet?
NGL Fine Chem generated consolidated net cash flow from operating activities of Rs 35.80 crore in the half year ended September 2026, compared with Rs 16.77 crore in the prior-year period. Cash generated from operations rose to Rs 47.22 crore from Rs 22.71 crore, while net income tax paid increased to Rs 11.43 crore from Rs 5.93 crore.
Working-capital movements included a Rs 48.10 crore increase in inventories and a Rs 5.88 crore increase in trade receivables. These cash uses were partly offset by a Rs 22.75 crore increase in trade payables, and cash and cash equivalents stood at Rs 5.05 crore on September 30, 2026, compared with Rs 2.81 crore on March 31, 2026.
Net cash used in investing activities was Rs 44.05 crore, compared with Rs 26.66 crore a year earlier, including Rs 44.25 crore spent on property, plant and equipment, capital work in progress and intangible assets. Financing activities generated Rs 10.50 crore, with Rs 19.40 crore of proceeds from current borrowings and Rs 5.72 crore of repayment of non-current borrowings.
Consolidated total assets were Rs 627.75 crore at September 30, 2026, compared with Rs 545.50 crore at March 31, 2026. Property, plant and equipment stood at Rs 285.50 crore versus Rs 163.80 crore, inventories were Rs 118.38 crore versus Rs 70.28 crore, and total borrowings were Rs 122.11 crore versus Rs 108.43 crore.
Conclusion
NGL Fine Chem’s September-quarter result combined a Rs 38.45 crore year-on-year increase in revenue from operations with a Rs 6.62 crore increase in consolidated profit after tax. Over the half year ended September 30, 2026, profit after tax reached Rs 34.64 crore as revenue from operations rose to Rs 297.87 crore, although September-quarter profit was below the Rs 18.40 crore reported in June.
The filing discloses no earnings target, operating forecast or scheduled future event. The next reported figures can show the effect of the Rs 48.10 crore inventory increase, Rs 44.25 crore capital expenditure and Rs 122.11 crore of consolidated borrowings recorded at September 30, 2026.


